GNMSF
Genmab A/S
Set alert
- YTD
- +79.56%
- 1 year
- +99.16%
- Open
- 572.00
- Prev close
- 555.30
- Mkt cap
- 34.67B
- Vol
- 661
- Avg vol
- 2.26K
- EPS
- 12.66
- P/E
- 44.54
More statistics
- Low
- 572.00
- High
- 578.00
- Earnings
- Nov 5, 2026
News
5 months ago seekingalpha.com
Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript
Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript
7 months ago defenseworld.net
Genmab A/S (OTCMKTS:GNMSF) Stock Price Crosses Below 200 Day Moving Average – Here’s Why
Genmab A/S (OTCMKTS:GNMSF - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $305.26 and traded as low as…
7 months ago seekingalpha.com
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
8 months ago seekingalpha.com
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
9 months ago seekingalpha.com
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
From a sector perspective, strength within Industrials and Information Technology offset relative weakness in Health Care. The October earnings report reinforced confidence in Comfort Systems'…
9 months ago seekingalpha.com
Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
10 months ago seekingalpha.com
Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript
Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript
11 months ago seekingalpha.com
Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
11 months ago seekingalpha.com
Genmab A/S (GMAB) Presents at Jefferies London Healthcare Conference 2025 Transcript
Genmab A/S (GMAB) Jefferies London Healthcare Conference 2025 November 19, 2025 7:00 AM EST Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - Executive VP & CFO…
11 months ago seekingalpha.com
Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript
Genmab A/S (GMAB) Q3 2025 Earnings Call November 6, 2025 12:00 PM EST Company Participants Jan van de Winkel - Co-Founder, President & CEO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head…
1 year ago seekingalpha.com
Genmab A/S (GMAB) M&A Call Transcript
Genmab A/S (GMAB) M&A Call September 29, 2025 7:00 AM EDT Company Participants Jan van de Winkel - Co-Founder, President & CEO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head of…
1 year ago seekingalpha.com
Genmab A/S (GMAB) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Genmab A/S (GMAB) Bank of America Global Healthcare Conference 2025 September 23, 2025 6:35 AM EDT Company Participants Anthony Pagano - Executive VP & CFO Conference Call Participants Sachin Jain -…
1 year ago seekingalpha.com
Genmab A/S (GMAB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Genmab A/S (GMAB) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - Executive…
1 year ago seekingalpha.com
Genmab A/S (GMAB) Q2 2025 Earnings Call Transcript
Genmab A/S (GMAB) Q2 2025 Earnings Conference Call August 7, 2025 12:00 PM ET Company Participants Anthony Pagano - Executive VP & CFO Brad Bailey - Corporate Participant Jan G.J. van de Winkel -…
1 year ago seekingalpha.com
Genmab A/S (GMAB) Q4 2024 Earnings Conference Call Transcript
Genmab A/S (GMAB) Q4 2024 Earnings Conference Call February 12, 2025 12:00 PM ET Company Participants Jan van de Winkel - CEO Brad Bailey - EVP and Chief Commercial Officer Anthony Pagano - CFO…
1 year ago seekingalpha.com
Genmab A/S (GMAB) Q3 2024 Earnings Conference Call Transcript
Genmab A/S (GMAB) Q3 2024 Earnings Conference Call November 6, 2024 12:00 PM ET Company Participants Jan van de Winkel - CEO Brad Bailey - EVP and Chief Commercial Officer Anthony Pagano - CFO Judith…
2 years ago globenewswire.com
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; September 26, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees…
2 years ago globenewswire.com
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement COPENHAGEN, Denmark; September 10, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 11,729 shares as a consequence of the exercise of employee warrants. The…
2 years ago globenewswire.com
Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Media Release COPENHAGEN, Denmark; August 26, 2024 Genmab A/S (Nasdaq: GMAB ) a nnounced today that its Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano…
2 years ago seekingalpha.com
Genmab: Strong H1 2024 Performance, Partner BioNTech Gives Up On Acasunlimab
Genmab's stock continues to struggle despite the strong progress of the company's commercial portfolio in the first half of the year. Epkinly is now FDA-approved for third-line+ follicular lymphoma,…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday